Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,627 High Blood Pressure (Hypertension)
clinical trials

Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Falls Church, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Torrance, CA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Albany, NY
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Lincoln, NE
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Newark, NJ
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Pomona, CA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Providence, RI
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
San Juan Capistrano, CA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Troy, MI
Click here to add this to my saved trials
Open Angle Glaucoma -Ocular Hypertension Clinical Trial
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling, Phase I
Updated: 3/18/2016
mi
from
St Joseph, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Darlinghurst,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Fairfield, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Status: Enrolling, Phase II
Updated: 1/22/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Bruxelles - Brussel,
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Rochester, NY
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Detroit, MI
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Liverpool, NY
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Marietta, GA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Pulmonary Clinical Trial
MOTION, Measuring Outcomes in Treatment Naive Patients
Status: Enrolling, Phase IV
Updated: 2/14/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Open Angle Glaucoma -Ocular Hypertension Clinical Trial
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling, Phase I
Updated: 3/18/2016
mi
from
Roswell, GA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
El Paso, TX
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Fairfield, OH
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
Status: Enrolling, Phase II
Updated: 1/27/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Hypertension Clinical Trial
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling, Phase III
Updated: 2/18/2016
mi
from
Rosario,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Brandon, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Elkridge, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Lexington, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Morganville, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Raleigh, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Tustin, CA
Click here to add this to my saved trials
Hypertension, Glaucoma, Open-Angle Clinical Trial
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Morrow, GA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Status: Enrolling, Phase III
Updated: 12/2/2015
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Newark, NJ
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Providence, RI
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
Status: Enrolling
Updated: 1/20/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Avondale, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Glendale, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Jackson, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Metairie, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Plano, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Renton, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Topeka, KS
Click here to add this to my saved trials
Hypertension, Glaucoma, Open-Angle Clinical Trial
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Sofia,
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Status: Enrolling, Phase III
Updated: 12/2/2015
mi
from
Bainbridge, GA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Status: Enrolling, Phase III
Updated: 12/2/2015
mi
from
Camperdown,
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Status: Enrolling, Phase III
Updated: 12/2/2015
mi
from
Duluth, GA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Aurora, CO
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
Status: Enrolling, Phase II
Updated: 1/27/2016
mi
from
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
Status: Enrolling, Phase II
Updated: 1/27/2016
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Auburn, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Dearborn, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Pismo Beach, CA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Omaha, NE
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hypertension, Pulmonary Clinical Trial
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 1/5/2016
mi
from
Weston, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
Status: Enrolling, Phase II
Updated: 1/27/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Altoona, PA
Click here to add this to my saved trials
1 18 19 20 21 22 23 24 25 26